Suppliers / Beacon Pharmaceuticals

Beacon Pharmaceuticals

Bangladesh Updated 9 July 2026

Beacon Pharmaceuticals is a finished-dose manufacturer based in Bangladesh. It appears in 145 regulatory filings across 4 regulators, without an active US DMF or CEP on file. Its filings concentrate with HSA (SG), UZPHARM (UZ) and ARCSA (EC). Its GMP standing is certified by HSA (SG) and FDA (GH).

0
active US DMFs
0
valid CEPs
0
registered plants
145
filings across 4 regulators

Filings and GMP by regulator

Regulator Filings GMP certificates
HSA (SG) 111 4
UZPHARM (UZ) 26 None
ARCSA (EC) 6 None
MPA (SE) 2 None
FDA (GH) None 1

Limited public record

Beyond the filing counts above, the public registers hold no plant, inspection or portfolio detail for this company as at 9 July 2026. We report that as a gap rather than inferring an answer.

Questions about Beacon Pharmaceuticals

Does Beacon Pharmaceuticals hold a US DMF or a CEP?
No active US drug master file or valid CEP is on record for Beacon Pharmaceuticals. It does have 145 filings with 4 regulators, so it is registered, just not with the two strong registers buyers usually screen on.
Which regulators recognise Beacon Pharmaceuticals's GMP?
Current GMP certificates are on record from HSA (SG) and FDA (GH). GMP recognition covers the manufacturing site, separately from any filing on the substance itself.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Beacon Pharmaceuticals comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates